CDSCO
The Central Drugs Laboratories have identified 41 Drug Samples to be ‘Not of Standard Quality’ (NSQ) and State Drugs Testing Laboratories have identified 70 Drugs Samples as Not of Standard Quality (NSQ) for the month of Nov 2024.
Further, 2 drug samples have been identified as ‘spurious drugs’, out of 2 samples, 1 drug sample has been picked by Bihar Drugs Control Authority and 1 sample by CDSCO (NZ), Ghaziabad. The CDSCO said that these drugs have been made by unauthorized and unknown manufacturers, using brand names owned by other companies.
The CDSCO said an investigation has been initiated in the case.
“Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by the Govt. Laboratory and it does not warrant any concerns on the other drug products available in the market”, said the CDSCO.
In recent years, the increasing prevalence of coronary artery disease (CAD) in individuals under 50…
Prime Minister Narendra Modi on Sunday visited the All India Institute of Medical Science to…
One of the biggest economic burdens caused by air pollution is healthcare expenses. Polluted air…
Union health minister JP Nadda on Tuesday chaired the ninth meeting of Mission Steering Group…
On the occasion of World Obesity Day, the All India Institute of Medical Sciences (AIIMS)…
Nowadays, there are several things in our kitchen that are slowly harming our health and…